N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141346 |
| CAS No | NA |
| Mol.F. | C6H11N3O5 |
| Mol.Wt. | 205.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141347 |
| CAS No | NA |
| Mol.F. | C4H7N3O3 |
| Mol.Wt. | 145.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141348 |
| CAS No | NA |
| Mol.F. | C16H22N12O3S5 |
| Mol.Wt. | 590.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141349 |
| CAS No | NA |
| Mol.F. | C7H4N6O3 |
| Mol.Wt. | 220.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141350 |
| CAS No | NA |
| Mol.F. | C12H14N2O4 |
| Mol.Wt. | 250.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141351 |
| CAS No | NA |
| Mol.F. | C11H6Br2N2O2 |
| Mol.Wt. | 358.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141352 |
| CAS No | NA |
| Mol.F. | C8H10N2O3 |
| Mol.Wt. | 182.18 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141353 |
| CAS No | NA |
| Mol.F. | C20H20N2O8 |
| Mol.Wt. | 416.39 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141354 |
| CAS No | NA |
| Mol.F. | C15H14N24 |
| Mol.Wt. | 286.29 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141355 |
| CAS No | NA |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141356 |
| CAS No | NA |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141357 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141358 |
| CAS No | NA |
| Mol.F. | C11H12N2O3 |
| Mol.Wt. | 220.23 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141359 |
| CAS No | NA |
| Mol.F. | C17H19N5OS |
| Mol.Wt. | 341.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141360 |
| CAS No | NA |
| Mol.F. | C26H27N5O4 |
| Mol.Wt. | 473.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141361 |
| CAS No | 23040-64-4 |
| Mol.F. | C7H8N2O2 |
| Mol.Wt. | 152.15 g/mol |
| INV STATUS | In Stock |